Prostate cancer impacts some 200,000 American men every year. But, fascinating research happening right here in North Texas could one day provide new options for early detection and treatment.
Beating cancer, by telling people, to “buzz-off.” It’s a growing New England event that’s now expanding to North Texas, thanks to an Allen family who suffered a great loss more than 20 years ago.
A North Texas hospital is performing groundbreaking breast cancer research. Doctors are using cutting edge medical technology to customize treatment.
A new study shows how important it is for men to carefully consider treatments for early-stage prostate cancer. Fifteen years after surgery or radiation treatment, nearly all of the older men in the study had some problems having sex.
A troubled $3 billion cancer-fighting agency in Texas under criminal investigation must address “significant issues” with accountability and transparency.
The executive director of a troubled $3 billion cancer-fighting effort in Texas has submitted his resignation letter amid escalating scrutiny over the management of the nation’s second-biggest pot of cancer research dollars.
Breast cancer patients taking the drug tamoxifen can cut their chances of having the disease come back or kill them if they stay on the pills for 10 years instead of five years as doctors recommend now, a major study finds.
It may have looked like a massive party in the halls of Arlington Martin High School, but it was actually something even cooler.
Disgraced cycling great Lance Armstrong has cut ties with his cancer-fighting charity,Livestrong, amid his doping scandal.
Aspirin, one of the world’s oldest and cheapest drugs, has shown remarkable promise in treating colon cancer in people with mutations in a gene that’s thought to play a role in the disease.
How can a cancer come back after it’s apparently been eradicated? Three new studies, including one by a Texas, are bolstering a long-debated idea: that tumors contain their own pool of stem cells that can multiply and keep fueling the cancer, seeding regrowth.
The state’s $3 billion cancer research initiative has changed course and will give a scientific review to an already approved project that led to a top agency executive resigning in protest.